Close
Help
Login
Staff Login
Register
FR
0
Selected
Invert selection
Deselect all
Deselect all
Add to Cart
Click here to refresh results
Click here to refresh results
Go to Login page
Hide details
Conceptually similar
CP121579471 | US recommends 'pause' for J&J vaccine over clots
CP121583621 | US recommends 'pause' for J&J vaccine
CP120476771 | AstraZeneca vaccine's benefits vastly outweigh risks: Sharma
CP121585521 | Fauci reminds of small risk for J&J vaccine
CP122094921 | Probe after blood clot death linked to vaccine
CP121584821 | Canada probing J&J vaccine blood-clot reports
CP121601421 | Colorado among US states to pause JandJ vaccine
CP121635062 | AstraZeneca vaccine to remain authorized in Canada
CP121585560 | Newsroom Ready: Canada probing J&J vaccine blood-clot reports
CP121635021 | CDC: J&J pause shows safety system is working
US resumes J&J vaccinations despite rare clot risk
U.S. health officials lifted an 11-day pause on COVID-19 vaccinations using Johnson & Johnson's single-dose shot on Friday, after scientific advisers decided its benefits outweigh a rare risk of blood clot. (April 23)
Actions
Add to collection
Add to cart
Information
Source name:
The Associated Press
Unique identifier:
CP122152571
Legacy Identifier:
454fb6a3457048e5a33a152f2444c68c
Type:
Video
Duration:
46s
Dimensions:
1920px × 1080px 56.57 MB
Usage rights:
Digital platform use only. Broadcast rights and editing of content prohibited.
Create Date:
4/23/2021 8:21:33 PM
Display aspect ratio:
16:9